These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 22207972)

  • 1. [International trends and future perspectives on screening for prostate cancer].
    Ito K
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():207-11. PubMed ID: 22207972
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer.
    Shteynshlyuger A; Andriole GL
    J Urol; 2011 Mar; 185(3):828-32. PubMed ID: 21239021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two randomized screening trials with prostate cancer mortality, two interim results: a consideration of usual-care window in screening trials.
    Song Y
    Contemp Clin Trials; 2010 Jul; 31(4):378-80. PubMed ID: 20450987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Terris MK
    Eur Urol; 2009 Feb; 55(2):392; discussion 393. PubMed ID: 18353530
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate-specific antigen: a new(ish) study.
    Harv Mens Health Watch; 2010 Nov; 15(4):6-8. PubMed ID: 21166115
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy vs effectiveness in prostate-specific antigen screening.
    Albertsen PC
    J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial results did not resolve controversies surrounding prostate cancer screening.
    Hoffman RM
    Curr Opin Urol; 2010 May; 20(3):189-93. PubMed ID: 20224414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer.
    Otto SJ; Moss SM; Määttänen L; Roobol M; Zappa M; Nelen V; Kwiatkowski M; Villers A; Hugosson J; Sanchez AB; de Koning HJ
    Eur J Cancer; 2010 Nov; 46(17):3053-60. PubMed ID: 21047586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
    Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
    Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilogue: different approaches for prostate cancer screening in the EU?
    Schröder FH; Denis L; Roobol MJ
    Eur J Cancer; 2010 Nov; 46(17):3120-5. PubMed ID: 21047595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer screening and mortality: comparison of recent randomized controlled clinical trials.
    Mian BM
    Urol Oncol; 2010; 28(3):233-6. PubMed ID: 20097584
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
    Schröder FH; Roobol MJ
    BJU Int; 2009 Jan; 103(2):143-4. PubMed ID: 19076150
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of a randomized controlled trail of prostate cancer screening.
    Pinsky PF
    Prostate; 2004 Dec; 61(4):371. PubMed ID: 15503321
    [No Abstract]   [Full Text] [Related]  

  • 15. Rural residence and prostate cancer screening with prostate-specific antigen.
    Stamatiou K; Skolarikos A
    Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for prostate cancer: practical analysis of the ERSPC [corrected] and PLCO trials.
    Djavan B
    Eur Urol; 2011 Mar; 59(3):365-9. PubMed ID: 21159418
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate-cancer screening.
    Catalona WJ
    N Engl J Med; 2009 Jul; 361(2):202; author reply 204-5. PubMed ID: 19587348
    [No Abstract]   [Full Text] [Related]  

  • 18. Perspective on prostate cancer screening.
    Rogers CS
    Int J Clin Pract; 2011 Jan; 65(1):31-4. PubMed ID: 21155942
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate cancer around the world. An overview.
    Schröder FH
    Urol Oncol; 2010; 28(6):663-7. PubMed ID: 21062647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A misleading paper on prostate cancer screening.
    Elwood M
    Prostate; 2004 Dec; 61(4):372; author reply 373-4. PubMed ID: 15503318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.